Discussion Paper Details

Please find the details for DP14861 in an easy to copy and paste format below:

Full Details   |   Bibliographic Reference

Full Details

Title: Disruptive Innovation and R&D Ownership Structures of the Firm

Author(s): Di Guo, Haizhou Huang, Kun Jiang and Chenggang Xu

Publication Date: June 2020

Keyword(s): Capitalism, Innovation, Socialism and Soft-budget Constraint

Programme Area(s): Development Economics, Financial Economics and Industrial Organization

Abstract: Among the 87 revolutionary innovations in the world over the life of the Soviet Union, 86 were invented in capitalist economies (Kornai, 2013). This paper studies why this is the case. This paper provides a theoretical foundation, which explains why disruptive innovations are organized and financed with a large number of independent small firms in a capitalist economy. Whereas not allowing private ownership, this kind of arrangement is not an option in an economy where only state ownership exists. This paper also contributes to empirical work on disruptive innovation, which is missing in the literature. We use FDA approved new molecular entities (NMEs) in the pharmaceutical industry as a proxy of disruptive innovation in the industry. Although pharma firms are often very large in size, their R&Ds for developing NMEs depend deeply on forming R&D alliances with independent small R&D firms. We find NMEs invented by a pharma firm is positively and significantly associated with the number of R&D alliances that the firm creates.

For full details and related downloads, please visit:

Bibliographic Reference

Guo, D, Huang, H, Jiang, K and Xu, C. 2020. 'Disruptive Innovation and R&D Ownership Structures of the Firm'. London, Centre for Economic Policy Research.